Substitution Of Medical Cannabis For Pharmaceutical Agents For Pain, Anxiety, And Sleep

Pain (Chronic Non-Malignant) Insomnia Anxiety

Key Findings

Approximately two-thirds of patients decreased their use of anti-anxiety (71.8%), migraine (66.7%), and sleep (65.2%) medications following medical cannabis. In conclusion, a majority of patients reported using less opioids as well as fewer medications to treat anxiety, migraines, and sleep after initiating medical cannabis. A smaller portion used less antidepressants or alcohol.

Information and Links


Link: Substitution Of Medical Cannabis For Pharmaceutical Agents For Pain, Anxiety, And Sleep

Year: 2017

DOI: 10.1177/0269881117699616


Ratings

(How Ratings Work)

Pain (Chronic Non-Malignant) — 3


Likely probability of the efficacy of cannabis for treatment of Pain (Chronic Non-Malignant) according to the results found in this study.

Insomnia — 3


Likely probability of the efficacy of cannabis for treatment of Insomnia according to the results found in this study.

Anxiety — 3


Likely probability of the efficacy of cannabis for treatment of Anxiety according to the results found in this study.

Drugs Used

Cannabis